Forian Inc. provides a suite of software solutions, data management capabilities, and proprietary data and predictive analytics to optimize and measure operational, clinical, and financial performance for customers within the healthcare and cannabis industries, as well as cannabis dispensaries, cultivators, manufacturers, and distributors. The company is headquartered in Newtown, Pennsylvania.
IPO Year:
Exchange: NASDAQ
Website: forian.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/20/2023 | $5.00 | Buy | ROTH MKM |
| 4/8/2022 | $9.00 | Buy | Lake Street |
| 3/11/2022 | $35.00 → $32.00 | Outperform | RBC Capital |
| 11/11/2021 | $34.00 → $35.00 | Outperform | RBC Capital |
| 7/9/2021 | $31.00 | Outperform | RBC Capital |
NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa. Forian Inc. (NASDAQ:FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. "While this quarter's revenue remained steady, our team's commitment to driving long-term value has resulted in progress in our strategic vision. The addition of Kyber Data Science enhances the momentum we are building to position us well to capitalize on emerging opportunities and deliver sustained success for our stakeholders," stated Max Wygod, Chairman and Chief Executive Officer of Foria
NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, and Mike Vesey, Chief Financial Officer, will attend ROTH MKM's 13th annual Technology Event, which will be held on November 19th – 20th, 2024, at the Hard Rock Hotel in New York City. This year's event will consist of 1-on-1 / small group meetings with over 70 innovative growth companies spanning the technology landscape. The format will provide investors with the opportunity to hear from and meet executive management from public and pre-public companies across various Technology sub-sectors. Each meeting will consist of a 40-minute se
NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/rj92ayah. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call pr
NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC ("Kyber"), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian's position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services. Kyber has established a leading reputation for its inno
NEWTOWN, PA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2024. "We continued to invest in our information assets in the second quarter to further differentiate our offerings and the insights they power for our customers. We remain confident that our combination of thoughtful productization, diversification of data sources and prudent cost containment put us in solid position to manage through recent industry challenges and to continue our contribution to our customers' success," stated Max
NEWTOWN, PA , Aug. 02, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 14, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/c5ot6k5y This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. "Forian finished the year by executing against our quarterly plan and closed what was a transformational year," stated Max Wygod, Chairman and Chief Executive Officer of Forian. "In 2023, we successfully completed a major divestiture and refocused our business on healthcare and life sciences, continued revenue growt
NEWTOWN, PA, March 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 28, 2024, to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/w4vcipvu. This information is also available on our website at www.forian.com/investors. The earnings release al
Third quarter revenue grew 24% year-over-year Forian data factory expanded to drive improved insights NEWTOWN, PA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended September 30, 2023. "Our strong financial quarter highlighted by an increase in Adjusted EBITDA is a testament to the hard work of the team and the scalability of our business model. We are committed to continuing to deliver valuable information products and intelligence to our customers. We continue to be prudent i
NEWTOWN, PA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2023 financial results on Thursday, November 9, 2023, after the close of the market. The Company will host a conference call and webcast at 5:00 p.m. (ET) on November 9, 2023, to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/uh4whvrn. This information is also available on our website at www.forian.com/investors. The earnings release along with a repla
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
4 - Forian Inc. (0001829280) (Issuer)
SC 13G/A - Forian Inc. (0001829280) (Subject)
SC 13G/A - Forian Inc. (0001829280) (Subject)
SC 13G - Forian Inc. (0001829280) (Subject)
SC 13G - Forian Inc. (0001829280) (Subject)
SC 13G - Forian Inc. (0001829280) (Subject)
SC 13G - Forian Inc. (0001829280) (Subject)
SC 13D - Forian Inc. (0001829280) (Subject)
NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa. Forian Inc. (NASDAQ:FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024. "While this quarter's revenue remained steady, our team's commitment to driving long-term value has resulted in progress in our strategic vision. The addition of Kyber Data Science enhances the momentum we are building to position us well to capitalize on emerging opportunities and deliver sustained success for our stakeholders," stated Max Wygod, Chairman and Chief Executive Officer of Foria
NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/rj92ayah. This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call pr
NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC ("Kyber"), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian's position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services. Kyber has established a leading reputation for its inno
NEWTOWN, PA, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2024. "We continued to invest in our information assets in the second quarter to further differentiate our offerings and the insights they power for our customers. We remain confident that our combination of thoughtful productization, diversification of data sources and prudent cost containment put us in solid position to manage through recent industry challenges and to continue our contribution to our customers' success," stated Max
NEWTOWN, PA , Aug. 02, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its second quarter 2024 financial results on Wednesday, August 14, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on August 14, 2024 to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/c5ot6k5y This information is also available on our website at www.forian.com/investors. The earnings release along with a replay of the call promptly
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. "Forian finished the year by executing against our quarterly plan and closed what was a transformational year," stated Max Wygod, Chairman and Chief Executive Officer of Forian. "In 2023, we successfully completed a major divestiture and refocused our business on healthcare and life sciences, continued revenue growt
NEWTOWN, PA, March 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 28, 2024, to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/w4vcipvu. This information is also available on our website at www.forian.com/investors. The earnings release al
Third quarter revenue grew 24% year-over-year Forian data factory expanded to drive improved insights NEWTOWN, PA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended September 30, 2023. "Our strong financial quarter highlighted by an increase in Adjusted EBITDA is a testament to the hard work of the team and the scalability of our business model. We are committed to continuing to deliver valuable information products and intelligence to our customers. We continue to be prudent i
NEWTOWN, PA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (NASDAQ:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2023 financial results on Thursday, November 9, 2023, after the close of the market. The Company will host a conference call and webcast at 5:00 p.m. (ET) on November 9, 2023, to discuss the results. To register for the conference call, click here. The webcast will be available live at https://edge.media-server.com/mmc/p/uh4whvrn. This information is also available on our website at www.forian.com/investors. The earnings release along with a repla
Second quarter revenue grew 36% year-over-year NEWTOWN, PA, Aug. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter ended June 30, 2023. "Forian's commitment to delivering value to our customers and shareholders in a more challenging fiscal environment is evident from another quarter of operational and financial achievements. We continued to realize the benefits of our business streamlining, cost rationalization and operating leverage to reduce our cash burn while showing positive Adjusted EBITDA and
ROTH MKM initiated coverage of Forian with a rating of Buy and set a new price target of $5.00
Lake Street initiated coverage of Forian with a rating of Buy and set a new price target of $9.00
RBC Capital reiterated coverage of VerticalScope Holdings with a rating of Outperform and set a new price target of $32.00 from $35.00 previously
RBC Capital reiterated coverage of VerticalScope Holdings with a rating of Outperform and set a new price target of $35.00 from $34.00 previously
RBC Capital initiated coverage of VerticalScope Holdings with a rating of Outperform and set a new price target of $31.00
10-Q - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
10-Q - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
10-Q - Forian Inc. (0001829280) (Filer)
8-K - Forian Inc. (0001829280) (Filer)
ARS - Forian Inc. (0001829280) (Filer)
DEFA14A - Forian Inc. (0001829280) (Filer)
4 - Forian Inc. (0001829280) (Issuer)
NEWTOWN, Pa., Sept. 1, 2021 /PRNewswire/ -- Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced the following: Convertible Notes Offering The Company has entered into a convertible note purchase agreement (the "Note Purchase Agreement") with a select group of institutional and accredited investors pursuant to which the Company will issue $24,000,000 aggregate principal amount at 100% of par value of its 3.5% convertible notes due 2025 (the "Notes"). The Notes are convertib
Forian (NASDAQ:FORA) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.02) by 100 percent. This is a 50 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $4.88 million which missed the analyst consensus estimate of $5.11 million by 4.56 percent. This is a 0.14 percent increase over sales of $4.87 million the same period last year.
Roth MKM analyst Richard Baldry reiterates Forian (NASDAQ:FORA) with a Buy and maintains $5 price target.
Forian (NASDAQ:FORA) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Forian beat estimated earnings by 67.0%, reporting an EPS of $-0.01 versus an estimate of $-0.03. Revenue was down $2.54 million from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.19 which was followed by a 8.0% increase in the share price the next day. Here's a look at Forian's past performance: Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022 EPS Estimate -0.03 -0.05 -0.11 -0.15 EPS Actual 0.16 -0.03 -0.08 -0.11 Revenue Estimate 5.22M 5.10M 5.70M 7.10M Revenue Actual 5.35M 4.8
Forian (NASDAQ:FORA) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 90.91 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $5.37 million which missed the analyst consensus estimate of $5.56 million by 3.44 percent. This is a 32.07 percent decrease over sales of $7.90 million the same period last year.
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated to report quarterly loss at $0.20 per share on revenue of $158.50 million. • MSC Industrial Direct Co (NYSE:MSM) is estimated to report quarterly earnings at $1.16 per share on revenue of $946.55 million. • Walgreens Boots Alliance (NASDAQ:WBA) is likely to report quarterly earnings at $0.75 per share on revenue of $33.03 billion. • Data Storage (NASDAQ:DTST) is projected to report earnings for its fourth quarter. • Affimed (NASDAQ:AFMD) is likely to report quarterly loss at $1.68 per shar
Forian (NASDAQ:FORA) is set to give its latest quarterly earnings report on Thursday, 2024-03-28. Here's what investors need to know before the announcement. Analysts estimate that Forian will report an earnings per share (EPS) of $-0.03. Forian bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter. New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast). Historical Earnings Performance Last quarter the company beat EPS by $0.19, which was followed by a 8.33% increase in the share price the
Gainers Exicure (NASDAQ:XCUR) stock increased by 29.8% to $0.8 during Wednesday's pre-market session. The company's market cap stands at $6.9 million. Telesis Bio (NASDAQ:TBIO) shares moved upwards by 21.88% to $0.46. The market value of their outstanding shares is at $13.6 million. Jin Medical International (NASDAQ:ZJYL) shares moved upwards by 21.33% to $110.0. The company's market cap stands at $852.5 million. Estrella Immunopharma (NASDAQ:ESLA) stock increased by 15.78% to $1.1. The company's market cap stands at $38.7 million. Amarin Corp (NASDAQ:AMRN) shares increased by 15.35% to $1.12. The market value of their outstanding shares is at $457.2 million. Bio-Path Hldgs (NASDAQ:BPT
Roth MKM analyst Richard Baldry initiates coverage on Forian (NASDAQ:FORA) with a Buy rating and announces Price Target of $5.
Forian (NASDAQ:FORA) reported its Q3 earnings results on Thursday, November 9, 2023 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Forian beat estimated earnings by 633.33%, reporting an EPS of $0.16 versus an estimate of $-0.03. Revenue was down $1.83 million from the same period last year. Past Earnings Performance Last quarter the company beat on EPS by $0.02 which was followed by a 1.54% drop in the share price the next day. Here's a look at Forian's past performance: Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022 EPS Estimate -0.05 -0.11 -0.15 -0.17 EPS Actual -0.03 -0.08 -0.11 -0.16 Revenue Estimate 5.10M 5.70M 7.10M 6.67M Revenue Actual 4.89M 4.
Forian (NASDAQ:FORA) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $(0.03) by 633.33 percent. This is a 200 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $5.35 million which beat the analyst consensus estimate of $5.22 million by 2.45 percent. This is a 25.47 percent decrease over sales of $7.18 million the same period last year.